Skip to main content

Novartis deal for Chinook makes kidney-treatment competitors more attractive, analysts say

Travere Therapeutics and Vera Therapeutics are also developing treatments for rare kidney disease
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.